nodes	percent_of_prediction	percent_of_DWPC	metapath
Gallamine Triethiodide—CHRNA2—forebrain—schizophrenia	0.0117	0.116	CbGeAlD
Gallamine Triethiodide—ACHE—telencephalon—schizophrenia	0.00869	0.0859	CbGeAlD
Gallamine Triethiodide—CHRNA2—blood—schizophrenia	0.00783	0.0775	CbGeAlD
Gallamine Triethiodide—CHRM2—forebrain—schizophrenia	0.00699	0.0691	CbGeAlD
Gallamine Triethiodide—CHRNA2—endocrine gland—schizophrenia	0.00679	0.0672	CbGeAlD
Gallamine Triethiodide—CHRM2—telencephalon—schizophrenia	0.00642	0.0635	CbGeAlD
Gallamine Triethiodide—CHRNA2—nervous system—schizophrenia	0.00636	0.0629	CbGeAlD
Gallamine Triethiodide—ACHE—midbrain—schizophrenia	0.00624	0.0617	CbGeAlD
Gallamine Triethiodide—CHRNA2—central nervous system—schizophrenia	0.00612	0.0605	CbGeAlD
Gallamine Triethiodide—CHRNA2—cerebellum—schizophrenia	0.00598	0.0592	CbGeAlD
Gallamine Triethiodide—CHRNA2—brain—schizophrenia	0.00486	0.0481	CbGeAlD
Gallamine Triethiodide—ACHE—cerebellum—schizophrenia	0.00483	0.0477	CbGeAlD
Gallamine Triethiodide—CHRM2—endocrine gland—schizophrenia	0.00405	0.0401	CbGeAlD
Gallamine Triethiodide—ACHE—brain—schizophrenia	0.00392	0.0388	CbGeAlD
Gallamine Triethiodide—CHRM2—nervous system—schizophrenia	0.00379	0.0375	CbGeAlD
Gallamine Triethiodide—CHRM2—central nervous system—schizophrenia	0.00365	0.0361	CbGeAlD
Gallamine Triethiodide—CHRM2—brain—schizophrenia	0.0029	0.0287	CbGeAlD
Gallamine Triethiodide—ACHE—Integrated Pancreatic Cancer Pathway—BDNF—schizophrenia	0.000699	0.000777	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Transmission across Chemical Synapses—MAOA—schizophrenia	0.000698	0.000776	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Integrated Pancreatic Cancer Pathway—ABCB1—schizophrenia	0.000687	0.000764	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—GRM2—schizophrenia	0.000687	0.000764	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—TAAR6—schizophrenia	0.000687	0.000764	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—SIDS Susceptibility Pathways—TH—schizophrenia	0.000685	0.000762	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—PRODH—schizophrenia	0.000679	0.000755	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Integrated Pancreatic Cancer Pathway—PLA2G4A—schizophrenia	0.000667	0.000742	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Class A/1 (Rhodopsin-like receptors)—CHRM1—schizophrenia	0.000665	0.00074	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Neuronal System—DLG4—schizophrenia	0.000658	0.000732	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of proteins—MAN2A1—schizophrenia	0.000643	0.000715	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Neuronal System—GRIN2B—schizophrenia	0.000643	0.000715	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Neuronal System—SLC6A3—schizophrenia	0.000633	0.000705	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCRs, Class A Rhodopsin-like—CCKAR—schizophrenia	0.000632	0.000704	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—PRKD1—schizophrenia	0.000624	0.000694	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—NTS—schizophrenia	0.000621	0.000691	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—G alpha (i) signalling events—NPY—schizophrenia	0.000617	0.000687	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of proteins—DPP4—schizophrenia	0.000616	0.000686	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCRs, Class A Rhodopsin-like—ADORA2A—schizophrenia	0.000613	0.000682	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—G alpha (i) signalling events—HTR1B—schizophrenia	0.000596	0.000663	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—GRM3—schizophrenia	0.000584	0.00065	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—SIDS Susceptibility Pathways—MAOA—schizophrenia	0.000578	0.000643	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—G alpha (i) signalling events—HTR1A—schizophrenia	0.000573	0.000638	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—HTR6—schizophrenia	0.000573	0.000638	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Class A/1 (Rhodopsin-like receptors)—CCK—schizophrenia	0.000565	0.000629	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—SIDS Susceptibility Pathways—BDNF—schizophrenia	0.000558	0.000621	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—MPC2—schizophrenia	0.000553	0.000615	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCRs, Class A Rhodopsin-like—HTR1B—schizophrenia	0.000553	0.000615	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Class A/1 (Rhodopsin-like receptors)—CCKAR—schizophrenia	0.000542	0.000603	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Neuronal System—COMT—schizophrenia	0.000539	0.000599	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—G alpha (i) signalling events—DRD3—schizophrenia	0.000536	0.000597	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Neuronal System—MAOA—schizophrenia	0.000535	0.000595	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—SIDS Susceptibility Pathways—IL10—schizophrenia	0.000533	0.000593	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCRs, Class A Rhodopsin-like—HTR1A—schizophrenia	0.000532	0.000592	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Class A/1 (Rhodopsin-like receptors)—ADORA2A—schizophrenia	0.000525	0.000585	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Integrated Pancreatic Cancer Pathway—ESR1—schizophrenia	0.000524	0.000583	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—G alpha (i) signalling events—DRD4—schizophrenia	0.000521	0.000579	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Calcium Regulation in the Cardiac Cell—YWHAZ—schizophrenia	0.00052	0.000578	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—SIDS Susceptibility Pathways—MEF2C—schizophrenia	0.000518	0.000577	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—CLOCK—schizophrenia	0.000516	0.000574	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—PLCH2—schizophrenia	0.000514	0.000572	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCRs, Class A Rhodopsin-like—DRD1—schizophrenia	0.000514	0.000572	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCRs, Class A Rhodopsin-like—HTR2C—schizophrenia	0.000514	0.000572	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—CHRM1—schizophrenia	0.000506	0.000563	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—SIDS Susceptibility Pathways—YWHAZ—schizophrenia	0.000501	0.000557	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCRs, Class A Rhodopsin-like—DRD3—schizophrenia	0.000498	0.000554	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—G alpha (i) signalling events—CNR1—schizophrenia	0.000497	0.000553	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Class A/1 (Rhodopsin-like receptors)—NPY—schizophrenia	0.000491	0.000546	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—DGKI—schizophrenia	0.000485	0.00054	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—G alpha (i) signalling events—DRD2—schizophrenia	0.000485	0.00054	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—NDST3—schizophrenia	0.000484	0.000538	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCRs, Class A Rhodopsin-like—DRD4—schizophrenia	0.000483	0.000538	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Class A/1 (Rhodopsin-like receptors)—OXT—schizophrenia	0.000474	0.000527	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR1B—schizophrenia	0.000474	0.000527	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—SIDS Susceptibility Pathways—HTR2A—schizophrenia	0.000472	0.000525	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—GRM5—schizophrenia	0.000471	0.000524	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCRs, Class A Rhodopsin-like—CNR1—schizophrenia	0.000461	0.000513	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—SLC27A5—schizophrenia	0.000458	0.00051	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—ACSL6—schizophrenia	0.000458	0.00051	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR1A—schizophrenia	0.000456	0.000507	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCRs, Class A Rhodopsin-like—DRD2—schizophrenia	0.00045	0.000501	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCRs, Class A Rhodopsin-like—HTR7—schizophrenia	0.00045	0.000501	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Class A/1 (Rhodopsin-like receptors)—NPS—schizophrenia	0.000449	0.0005	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—PIK3C2A—schizophrenia	0.000448	0.000498	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—DGKI—schizophrenia	0.000441	0.00049	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR2C—schizophrenia	0.00044	0.00049	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD1—schizophrenia	0.00044	0.00049	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—DAO—schizophrenia	0.000437	0.000486	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—CCK—schizophrenia	0.00043	0.000479	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD3—schizophrenia	0.000426	0.000474	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—PNP—schizophrenia	0.000419	0.000466	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD4—schizophrenia	0.000414	0.000461	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—CCKAR—schizophrenia	0.000413	0.000459	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—PPP1R1B—schizophrenia	0.000403	0.000448	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—ADORA2A—schizophrenia	0.0004	0.000445	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Class A/1 (Rhodopsin-like receptors)—CNR1—schizophrenia	0.000395	0.00044	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—NDUFV2—schizophrenia	0.00039	0.000434	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—TAAR6—schizophrenia	0.000388	0.000432	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—GRM2—schizophrenia	0.000388	0.000432	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR7—schizophrenia	0.000386	0.000429	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD2—schizophrenia	0.000386	0.000429	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—FZD3—schizophrenia	0.000375	0.000417	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—NPY—schizophrenia	0.000374	0.000416	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—PIP4K2A—schizophrenia	0.000366	0.000408	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—CYP1A2—schizophrenia	0.000363	0.000404	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—HTR1B—schizophrenia	0.000361	0.000401	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—OXT—schizophrenia	0.000361	0.000401	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—NGEF—schizophrenia	0.000359	0.000399	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—TAAR6—schizophrenia	0.000352	0.000392	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—GRM2—schizophrenia	0.000352	0.000392	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—PPP3CC—schizophrenia	0.000352	0.000392	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—NTS—schizophrenia	0.000351	0.00039	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—HTR1A—schizophrenia	0.000347	0.000386	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—NPS—schizophrenia	0.000342	0.00038	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—DRD1—schizophrenia	0.000335	0.000373	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—HTR2C—schizophrenia	0.000335	0.000373	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—CYP26B1—schizophrenia	0.000331	0.000369	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—GRM3—schizophrenia	0.00033	0.000367	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—RGS4—schizophrenia	0.00033	0.000367	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—NGEF—schizophrenia	0.000326	0.000363	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—DRD3—schizophrenia	0.000325	0.000361	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—HTR6—schizophrenia	0.000324	0.00036	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of proteins—ACE—schizophrenia	0.000319	0.000355	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—NTS—schizophrenia	0.000319	0.000355	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCRs, Class A Rhodopsin-like—HTR2A—schizophrenia	0.000315	0.000351	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—DRD4—schizophrenia	0.000315	0.000351	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Integrated Pancreatic Cancer Pathway—EP300—schizophrenia	0.000313	0.000348	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—CNR1—schizophrenia	0.000301	0.000335	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—GRM3—schizophrenia	0.0003	0.000333	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—RGS4—schizophrenia	0.0003	0.000333	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—TPH1—schizophrenia	0.000295	0.000329	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—GCLM—schizophrenia	0.000295	0.000329	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—HTR6—schizophrenia	0.000294	0.000327	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—DRD2—schizophrenia	0.000294	0.000327	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—HTR7—schizophrenia	0.000294	0.000327	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—CHRM1—schizophrenia	0.000286	0.000318	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—SIDS Susceptibility Pathways—IL1B—schizophrenia	0.000279	0.000311	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—IL3RA—schizophrenia	0.000279	0.00031	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—PLA2G4A—schizophrenia	0.000279	0.00031	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—PRKD1—schizophrenia	0.000278	0.000309	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR2A—schizophrenia	0.00027	0.000301	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—GRM5—schizophrenia	0.000266	0.000296	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—DGKI—schizophrenia	0.00026	0.00029	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—CHRM1—schizophrenia	0.00026	0.000289	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Integrated Pancreatic Cancer Pathway—TNF—schizophrenia	0.000254	0.000282	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—IL3RA—schizophrenia	0.000253	0.000282	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—SIDS Susceptibility Pathways—EP300—schizophrenia	0.00025	0.000278	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—CCK—schizophrenia	0.000243	0.000271	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—GRM5—schizophrenia	0.000242	0.000269	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—PPP1R1B—schizophrenia	0.000238	0.000265	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—PDE4B—schizophrenia	0.000237	0.000264	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—CCKAR—schizophrenia	0.000233	0.000259	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—GAPDH—schizophrenia	0.000232	0.000258	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—CLOCK—schizophrenia	0.00023	0.000256	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—APOE—schizophrenia	0.000229	0.000255	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—APOA1—schizophrenia	0.000227	0.000252	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—ADORA2A—schizophrenia	0.000226	0.000252	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—TPH2—schizophrenia	0.000224	0.000249	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—CACNB2—schizophrenia	0.000224	0.000249	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Integrated Pancreatic Cancer Pathway—TP53—schizophrenia	0.000224	0.000249	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—FZD3—schizophrenia	0.000221	0.000246	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—CCK—schizophrenia	0.000221	0.000246	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—DPYD—schizophrenia	0.00022	0.000245	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—PDE4B—schizophrenia	0.000215	0.000239	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—CCKAR—schizophrenia	0.000212	0.000236	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—NPY—schizophrenia	0.000211	0.000235	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—FES—schizophrenia	0.000208	0.000232	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—PPP3CC—schizophrenia	0.000208	0.000232	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—GRM2—schizophrenia	0.000208	0.000232	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—TAAR6—schizophrenia	0.000208	0.000232	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—HTR2A—schizophrenia	0.000206	0.000229	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—ADORA2A—schizophrenia	0.000205	0.000228	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—CACNA1C—schizophrenia	0.000205	0.000228	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—HTR1B—schizophrenia	0.000204	0.000227	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—OXT—schizophrenia	0.000204	0.000227	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—SIDS Susceptibility Pathways—TNF—schizophrenia	0.000203	0.000226	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—PIK3C2A—schizophrenia	0.0002	0.000222	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—HTR1A—schizophrenia	0.000196	0.000218	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—NPS—schizophrenia	0.000193	0.000215	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—NGEF—schizophrenia	0.000193	0.000214	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—NPY—schizophrenia	0.000192	0.000213	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—DRD1—schizophrenia	0.000189	0.000211	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—HTR2C—schizophrenia	0.000189	0.000211	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Integrated Pancreatic Cancer Pathway—AKT1—schizophrenia	0.000189	0.00021	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—NTS—schizophrenia	0.000188	0.000209	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—HTR1B—schizophrenia	0.000185	0.000206	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—OXT—schizophrenia	0.000185	0.000206	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—DRD3—schizophrenia	0.000184	0.000204	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—SNAP25—schizophrenia	0.000179	0.000199	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—CYP2D6—schizophrenia	0.000179	0.000199	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—HTR1A—schizophrenia	0.000178	0.000198	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—DRD4—schizophrenia	0.000178	0.000198	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—GRM3—schizophrenia	0.000177	0.000197	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—RGS4—schizophrenia	0.000177	0.000197	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—RTN4—schizophrenia	0.000177	0.000197	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—NPS—schizophrenia	0.000175	0.000195	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—HTR6—schizophrenia	0.000174	0.000193	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—DRD1—schizophrenia	0.000172	0.000191	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—HTR2C—schizophrenia	0.000172	0.000191	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—CNR1—schizophrenia	0.00017	0.000189	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—MAG—schizophrenia	0.000168	0.000187	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—DRD3—schizophrenia	0.000167	0.000185	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—DRD2—schizophrenia	0.000166	0.000185	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—HTR7—schizophrenia	0.000166	0.000185	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—CYP1A2—schizophrenia	0.000162	0.00018	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—DRD4—schizophrenia	0.000162	0.00018	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—TH—schizophrenia	0.00016	0.000177	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—CNR1—schizophrenia	0.000154	0.000172	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—CHRM1—schizophrenia	0.000153	0.000171	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—HTR7—schizophrenia	0.000151	0.000168	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—DRD2—schizophrenia	0.000151	0.000168	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—IL3RA—schizophrenia	0.00015	0.000166	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—NRG3—schizophrenia	0.000146	0.000162	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—TLE1—schizophrenia	0.000146	0.000162	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—GFAP—schizophrenia	0.000144	0.000161	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—GRM5—schizophrenia	0.000143	0.000159	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—TLE3—schizophrenia	0.000138	0.000154	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—COMT—schizophrenia	0.000136	0.000151	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—GSTP1—schizophrenia	0.000135	0.00015	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—MAOA—schizophrenia	0.000135	0.00015	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—EP300—schizophrenia	0.000131	0.000145	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—CCK—schizophrenia	0.00013	0.000145	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—ABCB1—schizophrenia	0.000128	0.000142	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—PDE4B—schizophrenia	0.000127	0.000141	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—CCKAR—schizophrenia	0.000125	0.000139	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—PLA2G4A—schizophrenia	0.000124	0.000138	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—GSTM1—schizophrenia	0.000124	0.000138	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—ADORA2A—schizophrenia	0.000121	0.000135	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—PLA2G4A—schizophrenia	0.000119	0.000133	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—FGA—schizophrenia	0.000116	0.000129	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—HTR2A—schizophrenia	0.000116	0.000129	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—NPY—schizophrenia	0.000113	0.000126	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—ATP2A2—schizophrenia	0.000113	0.000126	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—NOTCH4—schizophrenia	0.000113	0.000126	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—MTHFR—schizophrenia	0.00011	0.000122	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—HTR1B—schizophrenia	0.000109	0.000122	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—OXT—schizophrenia	0.000109	0.000122	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—HTR2A—schizophrenia	0.000106	0.000117	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—HTR1A—schizophrenia	0.000105	0.000117	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—NPS—schizophrenia	0.000104	0.000115	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—APOE—schizophrenia	0.000102	0.000114	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—DRD1—schizophrenia	0.000102	0.000113	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—HTR2C—schizophrenia	0.000102	0.000113	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—APOA1—schizophrenia	0.000101	0.000112	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—NTRK2—schizophrenia	9.89e-05	0.00011	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—DRD3—schizophrenia	9.85e-05	0.00011	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—DRD4—schizophrenia	9.56e-05	0.000106	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—CNR1—schizophrenia	9.13e-05	0.000102	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—DRD2—schizophrenia	8.9e-05	9.91e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—HTR7—schizophrenia	8.9e-05	9.91e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—PRL—schizophrenia	8.41e-05	9.35e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—S100B—schizophrenia	7.84e-05	8.72e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—ERBB4—schizophrenia	7.49e-05	8.34e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—PLA2G4A—schizophrenia	7.05e-05	7.84e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—NRG1—schizophrenia	6.92e-05	7.69e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—MEF2C—schizophrenia	6.85e-05	7.63e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—YWHAZ—schizophrenia	6.62e-05	7.37e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—ERBB3—schizophrenia	6.48e-05	7.21e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—HTR2A—schizophrenia	6.24e-05	6.94e-05	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—EP300—schizophrenia	5.82e-05	6.47e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—APOE—schizophrenia	5.8e-05	6.45e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—APOA1—schizophrenia	5.73e-05	6.38e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—ESR1—schizophrenia	5.53e-05	6.16e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—GSK3B—schizophrenia	5.02e-05	5.59e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—AKT1—schizophrenia	3.72e-05	4.14e-05	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—AKT1—schizophrenia	3.51e-05	3.91e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—AKT1—schizophrenia	3.38e-05	3.76e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—EP300—schizophrenia	3.3e-05	3.68e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—TP53—schizophrenia	2.36e-05	2.63e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—AKT1—schizophrenia	2e-05	2.22e-05	CbGpPWpGaD
